Cytogeneticists Say Platform Choice a Question of Personal Preference, Circumstance | GenomeWeb

CGH+SNP or just SNP? Geneticists who use microarrays for constitutional and cancer cytogenetics have never had so many choices. Four large vendors currently serve the market, and a number of other players sell a variety of designs optimized for different indications or communities.

But according to some longtime users of chromosomal microarrays, the decision of what platform to use often has more to do with the circumstances in which one adopts the technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.